Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges
Sofia Parrasia, Ildikò Szabó, Mario Zoratti, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 11, pp. 3700-3729
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Peptide-Based Agents for Cancer Treatment: Current Applications and Future Directions
Nguyễn Thị Thanh Nhàn, Tohru Yamada, Kaori Yamada
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12931-12931
Open Access | Times Cited: 55
Engineered Extracellular Vesicle-Delivered CRISPR/Cas9 for Radiotherapy Sensitization of Glioblastoma
Xiao Liu, Zhengcong Cao, Weizhong Wang, et al.
ACS Nano (2023) Vol. 17, Iss. 17, pp. 16432-16447
Open Access | Times Cited: 47
Cell-penetrating peptides for transmucosal delivery of proteins
Jiamin Wu, Sophie Roesger, Natalie Jones, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 864-878
Closed Access | Times Cited: 19
Blood–Brain Barrier-Targeting Nanoparticles: Biomaterial Properties and Biomedical Applications in Translational Neuroscience
Evridiki Asimakidou, Justin Kok Soon Tan, Jialiu Zeng, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 612-612
Open Access | Times Cited: 19
Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer
Ryan A. Bottens, Tohru Yamada
Cancers (2022) Vol. 14, Iss. 22, pp. 5546-5546
Open Access | Times Cited: 46
Cell-Penetrating and Targeted Peptides Delivery Systems as Potential Pharmaceutical Carriers for Enhanced Delivery across the Blood–Brain Barrier (BBB)
Soma Mondal Ghorai, Auroni Deep, Devanshi Magoo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1999-1999
Open Access | Times Cited: 39
Advances in the Repurposing and Blood–Brain Barrier Penetrance of Drugs in Pediatric Brain Tumors
Julian S. Rechberger, Stephanie Toll, Subhasree Biswas, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 439-439
Open Access | Times Cited: 1
New Trends in Brain Shuttle Peptides
Roger Prades, Meritxell Teixidò, Benjamí Oller‐Salvia
Molecular Pharmaceutics (2025)
Closed Access | Times Cited: 1
Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders
Yu Wu, Angelina Angelova
Nanomaterials (2023) Vol. 13, Iss. 23, pp. 3004-3004
Open Access | Times Cited: 22
A Promising Approach: Magnetic Nanosystems for Alzheimer’s Disease Theranostics
Catarina I. P. Chaparro, Beatriz Simões, João Paulo Borges, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2316-2316
Open Access | Times Cited: 12
Transforming brain cancer therapeutics: unlocking the power of blood-brain barrier-targeting strategies for superior treatment outcomes and precision medicine
Akshaya Viswanathan, Neha Brahma, S. Vimal
Neurosurgical Review (2024) Vol. 47, Iss. 1
Closed Access | Times Cited: 4
Nonviral targeted mRNA delivery: principles, progresses, and challenges
Xi He, Guohong Li, Li-Hsin Huang, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Peptides on patrol: Carrier systems for targeted delivery
Vivek P. Chavda, Joanna Bojarska
Progress in molecular biology and translational science (2025), pp. 129-161
Closed Access
Peptide‑based therapeutic strategies for glioma: current state and prospects
Yajing Mi, Pengtao Jiang, Jing Luan, et al.
Peptides (2025) Vol. 185, pp. 171354-171354
Closed Access
Polymer-based nanocarriers to transport therapeutic biomacromolecules across the blood-brain barrier
Elena Romero‐Ben, Upashi Goswami, Javier Cruz, et al.
Acta Biomaterialia (2025)
Open Access
New Trends in Peptide Therapies: Perspectives and Implications for Clinical Neurosciences
Wilfredo López-Ojeda, Robin A. Hurley
Journal of Neuropsychiatry (2025) Vol. 37, Iss. 2, pp. A6-101
Closed Access
Advances in cell-penetrating peptide-based nose-to-brain drug delivery systems
Shuai Hong, Jinlong Piao, Junsheng Hu, et al.
International Journal of Pharmaceutics (2025), pp. 125598-125598
Closed Access
The Role of Immune Dysfunction in Parkinson’s Disease Development
Davide Cossu, Taku Hatano, Nobutaka Hattori
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16766-16766
Open Access | Times Cited: 10
Encapsulated LyeTx III Peptide: Cytotoxic Agent Isolated from Lycosa erythrognatha Spider Venom
Daniel Moreira dos Santos, Lívia Ramos Santiago, Nayara Araújo dos Santos, et al.
Toxins (2025) Vol. 17, Iss. 1, pp. 32-32
Open Access
Trojan Horse Delivery Strategies of Natural Medicine Monomers: Challenges and Limitations in Improving Brain Targeting
Kelu Lei, Lanyu Zhou, M. Bostenaru Dan, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 280-280
Open Access
In Vivo Interrogation of Cell-Penetrating Peptide Function: Accumulation in Tumors and the Potential as a Specific PET Probe
Zhan Si, Lulu Tian, Hongxin Zhou, et al.
Bioconjugate Chemistry (2025)
Closed Access
In Vivo Cytosolic Delivery of Biomolecules into Neurons for Super‐Resolution Imaging and Genome Modification
Xiaoqian Ge, Joseph B. Wekselblatt, Scott Elmore, et al.
Advanced Science (2025)
Open Access
Food-Derived Peptides: Beneficial CNS Effects and Cross-BBB Transmission Strategies
Zehui Li, Qiao Dang, Peng Wang, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 51, pp. 20453-20478
Closed Access | Times Cited: 9
Patent landscape highlighting therapeutic implications of peptides targeting myristoylated alanine-rich protein kinase-C substrate (MARCKS)
Vikas Yadav, Amarish Kumar Sharma, Gaurav Parashar, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 6, pp. 445-454
Open Access | Times Cited: 7
Multitarget Ligands that Comprise Opioid/Nonopioid Pharmacophores for Pain Management: Current State of the Science
Émile Breault, Michael Desgagné, Jolien De Neve, et al.
Pharmacological Research (2024), pp. 107408-107408
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top